<DOC>
	<DOCNO>NCT03008031</DOCNO>
	<brief_summary>The optimal dose iodine base contrast agent use contrast-enhanced spectral mammography ( CESM ) unknown . If CESM , perform low dose iodine base contrast agent , visualize tumor comparable CESM regular dose contrast agent , patient receive less contrast agent CESM future thereby risk less side effect contrast agent . In order study whether CESM remain unchanged small amount contrast administration , second CESM exam perform within one week first alternative amount contrast , either 80 % , 60 % 40 % original contrast dose . The setting CESM unit remain unchanged .</brief_summary>
	<brief_title>Reduced Contrast Administration Contrast-enhanced Spectral Mammography ( CESM )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female patient histopathologically confirm invasive breast cancer recently underwent clinical CESM exam without complication ; Treated primary surgery ; Willing able undergo study procedure ; Has personally provide write informed consent . Age â‰¥ 18 Pregnancy Allergy ingredient ( Ultravist ) contrast agent Being unable give inform consent person History coronary arterial disease unstable angina Acute chronic severe renal insufficiency</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>